Moreover, our study on the mechanism confirmed that the JNK-MAPK/JUN/HK2 signaling pathway was involved in uMtCK-induced GC progression, offering a novel prognostic biomarker in GC patients after radical surgery. Here, JUN is linked to gastric cancer.